Search clinical trials for: Rituxan® (rituximab)
Total 16891 results
-
National Cancer Institute (NCI)RecruitingWaldenstrom Macroglobulinemia | Lymphoplasmacytic LymphomaUnited States
-
M.D. Anderson Cancer CenterDaiichi SankyoRecruiting
-
MingSight Pharmaceuticals, IncRecruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Aggressive LymphomaUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital and other collaboratorsTerminatedWaldenstrom's MacroglobulinemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedNonneoplastic ConditionUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Duke UniversityGlaxoSmithKlineCompletedLymphoma, B-CellUnited States
-
University Hospital, GhentBelgium Health Care Knowledge CentreCompleted
-
AI Therapeutics, Inc.CompletedLymphoma, Non-Hodgkin; Leukemia, Chronic LymphocyticUnited States
-
SCRI Development Innovations, LLCMillennium Pharmaceuticals, Inc.; CelgeneCompleted
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.Active, not recruitingWaldenstrom's MacroglobulinemiaUnited States
-
MedImmune LLCCompletedChronic Lymphocytic Leukemia (CLL)United States, France, Italy, Poland, Canada, Israel, Germany, Belgium
-
SCRI Development Innovations, LLCGenentech, Inc.; Celgene CorporationCompletedChronic Lymphocytic LeukemiaUnited States
-
Tehran University of Medical SciencesHoffmann-La RocheCompletedBehcet's SyndromeIran, Islamic Republic of
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedFollicular LymphomaGermany
-
PfizerCompletedRheumatoid ArthritisUnited States, Australia, Canada, Israel, Mexico, Colombia, Germany, Russian Federation, South Africa, United Kingdom
-
University of NebraskaNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedIdiopathic Thrombocytopenic PurpuraItaly
-
Jonathan FriedbergNational Cancer Institute (NCI); National Institutes of Health (NIH)Active, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma | Mucosal-Associated Lymphoid Tissue LymphomaUnited States
-
Dartmouth-Hitchcock Medical CenterSpectrum Pharmaceuticals, Inc; CephalonCompletedLymphoma, FollicularUnited States
-
SCRI Development Innovations, LLCInfinity Pharmaceuticals, Inc.CompletedStudy of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic MalignanciesLymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | T-cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States
-
Hoffmann-La RocheCompletedRheumatoid ArthritisRussian Federation
-
Northern Italy Leukemia GroupCompletedBurkitt Lymphoma | B-ALLItaly
-
TyrNovo Ltd.Active, not recruitingHead and Neck Cancer | Squamous Cell Carcinoma of Head and Neck | Metastatic Solid Tumor | Colorectal Adenocarcinoma | Solid Tumor, Adult | Recurrent Solid TumorUnited States, Israel
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Nektar TherapeuticsCompletedCervical Cancer | Colorectal Cancer | Head and Neck Squamous Cell Carcinoma | Anal Squamous Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States
-
Merck KGaA, Darmstadt, GermanyChoice Pharma TaiwanCompletedCarcinoma, Squamous Cell of Head and NeckTaiwan
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone... and other conditionsUnited States
-
Georg Hess, MDWyeth is now a wholly owned subsidiary of Pfizer; Mundipharma Pte Ltd.CompletedFollicular Lymphoma | Mantle Cell LymphomaGermany
-
Hoffmann-La RocheCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Waldenström Macroglobulinemia | Post-transplant Lymphoproliferative Disorder | Stage III Adult Burkitt Lymphoma | Stage III Adult Diffuse Large Cell Lymphoma | Stage IV Adult Burkitt Lymphoma | Stage IV Adult Diffuse...United States
-
Archigen Biotech LimitedCompletedLymphoma, FollicularUnited States, Korea, Republic of, Hungary, Spain, Turkey, Czechia, Italy, France, United Kingdom, Germany, South Africa, Australia, Chile, Mexico
-
East Valley Hematology and Oncology Medical GroupAstex Pharmaceuticals, Inc.; Pharmatech Oncology; Mena, Raul, M.D.UnknownEfficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.Chronic Lymphocytic LeukemiaUnited States
-
Hoffmann-La RocheCompletedRheumatoid ArthritisItaly
-
Singapore General HospitalJanssen-Cilag Ltd.CompletedDiffuse Large B-Cell LymphomaSingapore
-
US Oncology ResearchEli Lilly and CompanyCompletedRelapsed or Refractory Mantle Cell Lymphoma (MCL)
-
Emory UniversityCelgene CorporationTerminatedLeukemia, Lymphocytic, Chronic, B-Cell | Chronic Lymphocytic Leukemia | Lymphoma, Small LymphocyticUnited States
-
Hoffmann-La RocheTerminatedRheumatoid ArthritisNetherlands
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheActive, not recruitingDiffuse Large B-Cell LymphomaUnited States, United Kingdom, Korea, Republic of, Finland, Brazil, China, Mexico, Canada, Germany, India, Turkey, Greece, Italy, Spain, France, Ireland
-
Hoffmann-La RocheCompleted
-
University of CincinnatiGenzyme, a Sanofi Company; Millennium Pharmaceuticals, Inc.CompletedKidney TransplantationUnited States
-
Cerium Pharmaceuticals, Inc.RecruitingPrimary Membranous NephropathyUnited States, India, Canada
-
University of Colorado, DenverRocky Mountain MS Research Group, LLCCompletedMultiple SclerosisUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Non-Hodgkin LymphomaUnited States
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)RecruitingRecurrent Marginal Zone Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Indolent Adult Non-Hodgkin Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Recurrent Indolent Adult Non-Hodgkin...United States
-
National Cancer Institute (NCI)CompletedChronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Vaishalee KenkreEpizyme, Inc.; University of Wisconsin, MadisonRecruitingFollicular LymphomaUnited States